Ultragenyx Pharmaceutical (RARE) EBIT (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded EBIT of -$75 million in Q2 2026, compared with -$108 million a year earlier.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) EBIT (2013 - 2026) Analysis & Trends
On a TTM basis, Ultragenyx Pharmaceutical's EBIT came in at -$528.17 million as of Jun 30, 2026; for FY2025, it was -$535 million.
- Across earlier years, EBIT came in at -$536 million in FY2024, -$569 million in FY2023, -$648.92 million in FY2022 and -$381.74 million in FY2021.
- The Q2 2026 figure is the highest quarterly EBIT since Q3 2020.
- Per Business Quant, the preceding three quarters came in at -$169 million (Q1 2026), -$113.28 million (Q4 2025) and -$170.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.45 Bn | -348.90 Mn | 180.00 Mn | -75.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -75.00 Mn |
| Mar 31, 2026 | -169.00 Mn |
| Dec 31, 2025 | -113.28 Mn |
| Sep 30, 2025 | -170.89 Mn |
| Jun 30, 2025 | -108.00 Mn |
| Mar 31, 2025 | -143.00 Mn |
| Dec 31, 2024 | -122.31 Mn |
| Sep 30, 2024 | -131.99 Mn |
| Jun 30, 2024 | -116.36 Mn |
| Mar 31, 2024 | -165.35 Mn |
| Dec 31, 2023 | -121.84 Mn |
| Sep 30, 2023 | -145.10 Mn |
| Jun 30, 2023 | -147.96 Mn |
| Mar 31, 2023 | -154.11 Mn |
| Dec 31, 2022 | -145.63 Mn |
| Sep 30, 2022 | -225.07 Mn |
| Jun 30, 2022 | -141.59 Mn |
| Mar 31, 2022 | -136.63 Mn |
| Dec 31, 2021 | -102.56 Mn |
| Sep 30, 2021 | -89.83 Mn |
API Access
Ultragenyx Pharmaceutical EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();